Erbao Chen

1.9k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Erbao Chen is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erbao Chen has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 14 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erbao Chen's work include Ferroptosis and cancer prognosis (9 papers), Cancer, Lipids, and Metabolism (8 papers) and Cancer-related molecular mechanisms research (7 papers). Erbao Chen is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), Cancer, Lipids, and Metabolism (8 papers) and Cancer-related molecular mechanisms research (7 papers). Erbao Chen collaborates with scholars based in China, Ethiopia and Saudi Arabia. Erbao Chen's co-authors include Jian Zhou, Zheng‐Jun Zhou, Zhi Dai, Jia Fan, Shao‐Lai Zhou, Xiaowu Huang, Zhiqiang Hu, Zheng Wang, Ya Cao and Tianshu Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Erbao Chen

33 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib

2016 662 citations Shao‐Lai Zhou, Zheng‐Jun Zhou et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erbao Chen China	16	520	511	456	429	315	37	1.3k
Qihan Fu China	21	664 1.3×	629 1.2×	371 0.8×	518 1.2×	257 0.8×	44	1.5k
Jiaqiang Ma China	13	447 0.9×	431 0.8×	494 1.1×	294 0.7×	208 0.7×	18	1.2k
Jie-Yi Shi China	20	725 1.4×	471 0.9×	620 1.4×	306 0.7×	257 0.8×	31	1.6k
Maria O. Hernandez United States	5	378 0.7×	528 1.0×	284 0.6×	428 1.0×	189 0.6×	6	1.0k
Rakesh R. Ramjiawan United States	6	688 1.3×	434 0.8×	449 1.0×	282 0.7×	222 0.7×	7	1.3k
Yu Lou China	15	416 0.8×	525 1.0×	285 0.6×	403 0.9×	150 0.5×	28	1.1k
Jing-Jing Zhao China	25	813 1.6×	448 0.9×	786 1.7×	244 0.6×	154 0.5×	37	1.5k
De-Sheng Weng China	23	846 1.6×	470 0.9×	787 1.7×	210 0.5×	179 0.6×	33	1.6k
Seongyeol Park South Korea	17	430 0.8×	322 0.6×	239 0.5×	190 0.4×	209 0.7×	33	971
Qiu-Zhong Pan China	22	552 1.1×	442 0.9×	505 1.1×	203 0.5×	125 0.4×	26	1.1k

Countries citing papers authored by Erbao Chen

Since Specialization

Citations

This map shows the geographic impact of Erbao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erbao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erbao Chen more than expected).

Fields of papers citing papers by Erbao Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erbao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erbao Chen. The network helps show where Erbao Chen may publish in the future.

Co-authorship network of co-authors of Erbao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Erbao Chen. A scholar is included among the top collaborators of Erbao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erbao Chen. Erbao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zou, Zhilin, et al.. (2024). Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma. SHILAP Revista de lepidopterología. 53(6). 715–725.

Wang, Ting, et al.. (2024). Heterotopic pancreas in the gallbladder: A case report. World Journal of Clinical Cases. 12(22). 5140–5144.

Li, Qing, et al.. (2024). Efficacy of Jiuzao polysaccharides in ameliorating alcoholic fatty liver disease and modulating gut microbiota. Heliyon. 10(4). e26167–e26167. 4 indexed citations

Chen, Erbao, Zhilin Zou, Rongyue Wang, et al.. (2024). Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies. Frontiers in Immunology. 15. 1244392–1244392. 9 indexed citations

Zou, Zhilin, et al.. (2023). Targeting ferroptosis in hepatocellular carcinoma. Hepatology International. 18(1). 32–49. 14 indexed citations

Chen, Erbao, Jing Yi, Jie Liu, et al.. (2023). A novel hepatocellular carcinoma-specific mTORC1-related signature for anticipating prognosis and immunotherapy. Aging. 15(16). 7933–7955. 1 indexed citations

Chen, Erbao, Yu He, Jing Jiang, et al.. (2023). CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway. Experimental Hematology and Oncology. 12(1). 9–9. 22 indexed citations

Zhu, Guiqi, Yi Wang, Wei‐Ren Liu, et al.. (2022). Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 13(5). 1413–1447. 29 indexed citations

Chen, Erbao, et al.. (2022). Overexpression of SRD5A3 in Hepatocellular Carcinoma and Its Molecular Mechanism: A Study of Bioinformatics Exploration Analysis with Experimental Verification. Evidence-based Complementary and Alternative Medicine. 2022. 1–14. 1 indexed citations

10.

Li, Wei, Qian Li, Yiyi Yu, et al.. (2020). <p>Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma</p>. Cancer Management and Research. Volume 12. 11113–11119. 21 indexed citations

11.

Bo, Xiaobo, Erbao Chen, Jie Wang, et al.. (2019). Diagnostic accuracy of imaging modalities in differentiating xanthogranulomatous cholecystitis from gallbladder cancer. Annals of Translational Medicine. 7(22). 627–627. 25 indexed citations

12.

Zhu, Gui‐Qi, Yi Yang, Erbao Chen, et al.. (2019). Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Journal of Translational Medicine. 17(1). 203–203. 16 indexed citations

13.

Chen, Erbao, Zheng‐Jun Zhou, Kun Xiao, et al.. (2019). The miR-561-5p/CX₃CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX₃CR1⁺ Natural Killer Cells Infiltration. Theranostics. 9(16). 4779–4794. 96 indexed citations

14.

Chen, Erbao, et al.. (2019). ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression. Pathology - Research and Practice. 215(8). 152454–152454. 15 indexed citations

15.

Zhu, Guiqi, Kang Wang, Yujie Zhou, et al.. (2018). Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization. Cancer Management and Research. Volume 11. 63–79. 12 indexed citations

16.

Chen, Erbao, Xuan Qin, Ke Peng, et al.. (2018). Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis. Cellular Physiology and Biochemistry. 45(5). 1731–1746. 20 indexed citations

17.

Chen, Erbao, Xiaojing Xu, Ruiqi Liu, & Tianshu Liu. (2018). Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. BioMed Research International. 2018. 1–9. 33 indexed citations

18.

Chen, Qing, Dan Yin, Shiming Shi, et al.. (2017). Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinoma. Oncology Reports. 37(6). 3313–3320. 15 indexed citations

19.

Zhou, Shao‐Lai, Zheng‐Jun Zhou, Zhiqiang Hu, et al.. (2016). Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. Gastroenterology. 150(7). 1646–1658.e17. 662 indexed citations breakdown →

20.

Chen, Qing, Liu‐Xiao Yang, Dan Yin, et al.. (2015). The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy. Tumor Biology. 36(7). 5283–5289. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact